Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

Ellipse Recalled by St Jude Medical, Cardiac Rhythm Management Division Due to Past updates to programmers and transmitters may lead...

Date: January 22, 2020
Company: St Jude Medical, Cardiac Rhythm Management Division
Status: Terminated
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact St Jude Medical, Cardiac Rhythm Management Division directly.

Affected Products

Ellipse, Tiered-therapy Cardioverter/Defibrillator, REF (UDI/GTIN): CD1377-36QC (05414734507646), CD2411-36C (05414734507585), CD1277-36 (05414734506045), CD1377-36C (05414734507622), CD2277-36Q (05414734505932), CD2377-36QC (05414734507523), with Merlin Patient Care System with software model 3330

Quantity: 256

Why Was This Recalled?

Past updates to programmers and transmitters may lead some implantable cardioverter defibrillators (ICD) to lose wireless radiofrequency (RF) communication; which means patients can no longer be interrogated with wireless RF telemetry or monitored remotely.

Where Was This Sold?

This product was distributed to 19 states: AZ, CA, DE, FL, IN, KY, MD, MI, MS, MO, NJ, NY, NC, OH, OK, PA, TX, WA, WV

Affected (19 states)Not affected

About St Jude Medical, Cardiac Rhythm Management Division

St Jude Medical, Cardiac Rhythm Management Division has 2 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report